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Summary Fifteen consecutive patients with refractory or relapsed Hodgkin's disease (HD) referred for
autologous bone marrow transplantation (ABMT) underwent quantitative magnetic resonance (MR) studies of
the lumbar vertebral bone marrow. Markedly elevated lumbar vertebral marrow Ti values suggestive of bone
marrow involvement with HD were seen in four patients, two of whom had no evidence of HD on bilateral
iliac crest bone marrow biopsy. Serial studies showed normalisation of TI values in the post-transplant period.
Ti relaxation rate correlated positively with time to engraftment following ABMT and a significant correlation
(r = 0.73, 0.02>P> 0.01) between T2 relaxation rate and granulocye and macrophage colony forming units
(CFU-GM) of processed bone marrow was seen. This preliminary study illustrates the potential role of
quantitative MRI both in the pre-transplant assessment of patients considered for ABMT and in the
post-transplant evaluation of tumour response when marrow involvement with HD is present.
Magnetic resonance imaging (MRI) provides a safe non-
invasive means of assessing bone marrow (Volger & Murphy,
1988), which has been shown to be of value in detecting
marrow involvement by lymphoma (Olson et al., 1986;
Shields et al., 1987). Measurement of the proton relaxation
times Ti and T2 provides an objective means of characteris-
ing tissue. Elevated TI values have been reported in various
bone marrow disorders (Richards et al., 1988a; Nyman et al.,
1987; Smith et al., 1989), and preliminary studies have sug-
gested that serial quantitative MRI studies may be of value
in assessing treatment responses in acute leukaemia (Moore
et al., 1986; Thomsen et al., 1988).
Autologous bone marrow transplantation (ABMT) is an
effective treatment for refractory or relapsed Hodgkin's
disease (HD) (Jagannath et al., 1986), but the patient's bone
marrow has to be free of disease before being considered
suitable for such treatment. Detection of marrow involve-
ment by bone marrow biopsy in HD may be subject to
sampling error when assessing focal marrow involvement
(Kapadia & Krause, 1981). Bilateral posterior iliac crest bone
marrow biopsies improve detection rates in lymphoma but
still sample only a small volume of bone marrow (Brunning
et al., 1975). Quantitative MRI may therefore provide an
objective method of more accurately documenting the extent
of focal marrow involvement in patients with lymphoma and
may detect disease in patients with non-involved bilateral
iliac crest trephines.
Assessment of the engraftment potential of marrow
obtained at bone marrow harvest is conventionally made by
measuring total nucleated cell numbers and/or by evaluating
the numbers of colony forming units of the granulocyte/
macrophage line (CFU-GM) in cultured marrow. There is a
minimum number of nucleated cells of CFU-GM required to
support haemopoeitic reconstitution (Gorin, 1986). It has
been suggested that patients undergoing ABMT for refrac-
tory or relapsed HD are prone to more haemopoeitic toxicity
than patients receiving similar forms of treatment for other
malignancies (Phillips & Reece, 1986). Infections occurring in
the often prolonged period of neutropenia following ABMT
are an important cause of procedure-related morbidity and
mortality; therefore a non-invasive means of predicting those
at risk of delayed engraftment might have important implica-
tions for patient selection for ABMT. As the relaxation times
of marrow have been shown to relate closely to marrow
cellularity in health and pathological states (Nyman et al.,
1987; Dooms et al., 1985; Richards et al., 1988b; Smith et al.,
1989), quantitative MRI may provide a means of addressing
these problems in the pre-transplant period.
The aim of this preliminary prospective study was to assess
the role of quantitative MR studies in patients undergoing
ABMT for refractory or relapsed HD.
Methods
Fifteen consecutive patients (eight female, seven male, age
range 19-46 years) with relapsed or refractory Hodgkin's
disease referred for ABMT underwent quantitative MRI
studies of the lumbar spine. Studies were approved by the
local ethical committee and all subjects gave informed con-
sent to the MR studies.
All patients were studied before transplantation and within
1 week of the bone marrow harvest. Bilateral iliac crest bone
marrow trephines were performed on all patients before the
MR examination. Fifteen age and sex matched volunteers
served as normal controls. One normal volunteer was imaged
serially on four occasions over 64 days.
Thirteen patients received a conventional ABMT and two
patients received intensive chemotherapy followed by rescue
with peripherally harvested autologous stem cells. Seven
patients were studied serially in the post transplant period
(15-87 days post-transplantation).
MR studies were performed on a 1.5 Tesla GE Signa
system. The lumbar vertebral bone marrow was imaged with
a predefined reproducible protocol using spin-echo imaging
techniques (Smith et al., 1989). Quantitative data were
obtained from a single 10 mm thick midline saggital slice. TI
was derived from six images with varying repitition times
(TR) and T2 from four images with varying echo times (TE).
Two region-of-interest cursors were placed in each lumbar
vertebrae and computer derived TI and T2 values for the
bone marrow in individual lumbar vertebrae obtained. A
mean TI and T2 value was then calculated for the five
lumbar vertebrae. The total examination time was approx-
imately 50 min.
Bone marrow harvests were performed from the iliac crest
under general anaesthesia (Thomas & Storb, 1970) and bone
marrow cryopreserved with desmethyl sulphoxide after
plasma reduction. Pre-processing nucleated cell counts of
harvested bone marrow were performed and the CFU-GM of
the processed thawed bone marrow assayed (Broxmeyer et
al., 1983). The time to engraftment post-transplantation was
defined as the number of days to reach an absolute
neutrophil count of 0.5 x I091-. Regression analyses were
performed in the 11 patients with quantitatively normal pre-
transplant MR studies comparing MR parameters with the
time to engraftment, the yield from bone marrow harvest and
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CFU-GM potential of processed bone marrow. The
significance of the difference between mean Ti and T2 values
for controls and patients studied was analysed using Stu-
dent's t test where appropriate.
Results
Patient details
Patient characteristics, including sites of previous
radiotherapy, are summarised in Table I. Two of the patients
had positive bone marrow biopsies and were unsuitable for a
conventional ABMT (patients 8 and 9). Both these patients
received intensive chemotherapy with peripheral stem cell
rescue. The remaining 13 patients had no evidence of HD on
bilateral iliac crest bone marrow biopsy and underwent
ABMT with conditioning regimes as shown (Table I).
Pre-transplant MRI studies
The mean TI and T2 values for the control group were
771 ms (s.d. = 158, range 568-1041), and 42.0ms (s.d. = 6.6,
range 33.6-56.1) respectively. Mean lumbar vertebral Ti
values for the 15 patients are shown in Table I and Figures 1
and 2.
The patients with positive bone marrow biopsies showed two
patterns of altered signal intensity on TI weighted images.
One patient had focal areas of reduced signal intensity in the
lumbar marrow (Figure 3) while the other pattern was of
diffusely decreased signal throughout the lumbar vertebrae.
Two other patients (numbers 4 and 11) with no evidence of
HD on bilateral trephines also had abnormal MR studies.
Both had focal areas of altered signal intensity in the lumbar
vertebral marrow. In these four cases the lumbar vertebral
marrow Ti was markedly elevated compared with controls
consistent with marrow involvement by HD (Figure 1). The
variation in TI within each of these patients was large,
consistent with the focal nature of bone marrow involvement
with HD (Table I).
The MRI studies in the eleven other patients showed no
qualitative abnormalities in the lumbar marrow. The mean
Ti values in these patients (Mean TI 559 ms) was
significantly lower than controls (Mean TI 771 ms, P = 0.01).
There was a tendency for lumbar vertebral marrow T2 to
be higher in the patients with biopsy diocumented HD
(Figure 2), but a wide overlap in T2 value between other
patients and the control group existed.
Studies in the post-transplant period
Five patients with qualitatively normal pre-transplant MRI
scans were studied serially post-AMBT. In four of these
patients Ti decreased in the early post-transplantion period
(20-30 days) and then gradually recovered, in some cases to
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Figure 1 Mean lumbar vertebral marrow TI values for patients
referred for ABMT (O) and controls (*).
levels slightly higher than those pre-transplantation as
haemopoeitic recovery occurred (Figure 4). Changes in the
vertebral marrow TI mirrored the recovery of peripheral
blood neutrophil and platelet counts (Figure 5). In patient 1,
who had previously received radiotherapy to the lumbar
spine, little change in TI was seen. Serial studies in a normal
volunteer (four studies in 64 days) showed a variation in TI
of only 6%.
Of the four patients with abnormal pre-transplant MRI
studies and prolonged TI values, two were studied approx-
imately II weeks post-transplantation, after peripheral blood
counts had normalised. Both these patients showed a
significant reduction in Ti with treatment (Figure 6). These
Ti values post-transplantation were lower than those in the
control group but similar to pre-transplant values in the II
patients who underwent ABMT. A bone marrow biopsy in
the patient with previously documented HD was also now
normal.
The two other patients with abnormal MR studies could
not be studied post-transplantation. One patient died during
the procedure but post-mortem histology confirmed involve-
ment of the lumbar marrow with Hodgkin's disease. The
remaining patient refused further MRI studies.
There was a positive but not significant correlation
Table I Characteristics of consecutive patients referred for ABMT
Patient Previous Conditioning Pre-transplant (mean ± s.d.)
no. Age Sex radiotherap/ regimeb Ti T2
1 19 M Lumbar spine CBV 319 (65) 43.2 (2.4)
2 46 F Inverted Y CBV 523 (56) 43 (1.3)
3 32 F Mantle CBV 472 (24) 39.7 (3.4)
4 35 F - CBV 2010(1483) 51.3 (11.8)
5 24 M _ BEAM 584 (72) 37.1 (1.9)
6 28 F _ CBV 838 (124) 42.1 (2.9)
7 41 F - CBV 564 (74) 47.6 (2.7)
8 45 M Mantle BEAM 2552 (2202) 53.9 (9.5)
9 23 M Mantle BEAM 1914 (706) 48 (7.3)
10 44 M Mantle CBV 730 (98) 38.3 (3.4)
11 24 M Mantle CBV 1421 (539) 42.9(11)
Inverted Y
12 26 M Mantle CBV 657 (125) 45.6 (2.7)
13 37 F CBV 336 (40) 41.9 (3.9)
14 22 F Local neck CBV 445 (55) 39.2 (3.6)
15 25 F Mantle CBV 685 (100) 38.1 (1.8)
aAll patients had received one or two different combination chemotherapeutic regimes. bConditioning regimes used were: BEAM, carmustine
30mgm-2 day -6, etoposide 200mgm-2-5 to -2, cytrarabine 200 mgm-2 b.d. days -5 to -2, melphalan 140mgm-2 day -1; CBV,
cyclophosphamide 1.5 g m-2 day -6 to -3, carmustine 300 mg m-2 days -6, etoposide 100mg m-2 b.d. days -6 to -4.
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Figure 2 Mean lumbar vertebral marrow T2 values for patients
referred for ABMT (@) and controls (*).
Figure 3 TI weighted (TR/TE-750/25) sagittal image of the
lumbar spine of patient 8 with biopsy proven marrow involve-
ment with HD, showing reduced signal intensity in lumbar
vertebrae 2, 4 and 5 and partial involvement of vertebrae 3 and 1,
consistent with marrow involvement with Hodgkin's disease.
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Figure 4 Post-transplant studies of the five patients with
qualitatively normal pre-transplant MR studies showing changes
in mean TI with time after ABMT.
(r = 0.4, P = 0.1) between TI relaxation rate (1/Ti) and time
to engraftment following ABMT in the 11 patients with
qualitatively normal pre-transplant MR studies. No relation-
ship between TI and nucleated cell dose from bone marrow
harvest was seen. T2 relaxation rate (1/T2) correlated
positively with CFU-GM of the post-processed bone marrow
(r = 0.772, 0.02>P>0.01).
Discussion
Few techniques are available to study bone marrow non-
invasively. MRI is ideally suited to study bone marrow
(Vogler & Murphy, 1988) and potentially provides a quan-
titative, non-invasive method of characterising tissues and
more importantly of assessing objectively treatment res-
ponses. These preliminary studies have shown that quan-
titative MRI can detect abnormal areas suggestive of bone
marrow involvement in patients with HD. Significantly
elevated TI values were seen in patients with biopsy
documented bone marrow involvement with HD, and also in
two other patients with no biopsy evidence of marrow
involvement with HD. Serial studies allowed the response to
therapy to be evaluated objectively by following changes in
TI in the post-transplant period.
Although no biopsies of the lumbar vertebral marrow were
taken we are confident that these high TI values represented
focal areas of HD. Post-mortem examination of the lumbar
spine in the patient who suffered a procedure-related death
showed changes consistent with HD and the effects of high
dose chemotherapy. In addition the qualitative alterations in
signal intensity seen in these four patients is similar to that
previously reported in Hodgkin's disease (Olsen et al., 1986;
Shields et al., 1987), two patterns being seen on Ti weighted
images: focally decreased areas of signal intensity and
diffusely decreased signal intensity within the lumbar verte-
bral marrow.
This study suggests that certain patients undergoing
ABMT for HD may have bone marrow involvement that is
not detected by bilateral bone marrow biopsy from the iliac
crest, false negative results from marrow biopsy being seen in
two patients. This may well underestimate the extent of
marrow involvement in this particular patient group as only
the lumbar spine was imaged and HD may have existed in
other areas of haemopoeitic red marrow. As conventional
ABMT relies on the bone marrow being free of disease,
detection of bone marrow involvement has important im-
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Figure 5 Serial studies in the post-transplant period of patient 2, showing changes in TI (@) (mean ±s.d.) in relation to peripheral
blood platelet (A) and neutrophil (A) counts.
plications for improving patient selection. Those patients
with marrow involvement may be candidates for intensive
chemotherapy and rescue with peripherally harvested stem
cells (Kessinger et al., 1988).
The TI (spin-lattice) relaxation time of bone marrow has
been shown to relate closely to marrow cellularity in both
health and disease (Nymen et al., 1987; Dooms et al., 1985;
Richards et al., 1988b; Smith et al., 1989). Bone marrow Ti
decreases with age and this is thought to reflect the decreas-
ing cellularity and increasing fat content of bone marrow in
the elderly (Dooms et al., 1985; Richards et al., 1988b). The
elevated Ti seen in pathological tissues and malignant mar-
row infiltrates is due to alterations in the amount of free and
bound membrane water (Fullerton et al., 1982), and in addi-
tion changes in marrow cellularity, fat content, marrow
fibrosis and blood flow may be important.
The mean TI value of the lumbar marrow in the 11
patients with no MR evidence of HD was lower than age and
sex matched controls, reflecting the decreased cellularity of
the lumbar marrow in patients who had been exposed heavily
to chemotherapy. The lowest TI value of 319 ms was seen in
the patient who had previously had radiotherapy to the
lumbar spine.
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Figure 6 Mean TI (± s.d.) of patients with MR evidence of
Hodgkin's disease pre- and post-ABMT showing the effects of
therapy. The Ti of controls (*) is also shown.
The serial studies in the post-transplant period allowed the
effects of treatment to be assessed by following the changes
in the lumbar vertebral marrow TI. Serial studies in a nor-
mal volunteer were very reproducible with only a 6% varia-
tion in calculated TI. As quantitative data were obtained
from a single midline slice prescribed explicitly from a cor-
onal localising image it was possible to be confident that the
same area was being imaged in all patients studied serially.
In patients with no evidence of HD on biopsy or MR the
changes in Tl in the early post-transplant period re-
flected changes in marrow cellularity. Alterations in TI
mirrored changes in the peripheral blood platelet and neut-
rophil counts (Figure 5). In four of the five patients studied
in this subgroup Ti decreased following chemotherapy and
gradually recovered between days 30 and 50 to pre-transplant
levels. Patient I showed no changes of note post-ABMT,
presumably due to effects of previous radiotherapy on lum-
bar marrow.
The patients with evidence of marrow HD on biopsy or
MR showed a marked reduction of TI values post-
transplantation, consistent with a good response to therapy.
These observations parallel treatment responses seen in acute
leukaemia where Ti values have normalised with the attain-
ment of remission (Moore et al., 1986; Thomsen et al., 1988).
No other serial studies in patients with HD are available for
comparison. The very large variation in Ti pre-therapy seen
in the lumbar vertebrae in these four patients reflects the
focal nature of HD (Table I). The mean TI for the lumbar
vertebrae in these patients would have included normal areas
of bone marrow, reactive areas and areas involved by HD. A
marked reduction in Ti variance from 75 and 40% to less
than 15% was seen with therapy.
No relationship between pre-transplant MR parameters
and cell yield from bone marrow harvest could be estab-
lished. A positive correlation existed between pre-transplant
TI relaxation rate and time to engraftment. The longest time
to engraftment (39 days) was seen in the patient with the
shortest TI pre-transplantation. However, as these observa-
tions did not reach significance one could not confidently
predict those at risk of delayed engraftment. The correlation
between T2 relaxation rate and subsequent culture of CFU-
GM of processed bone marrow is difficult to explain as
progenitors committed to the granulocyte/macrophage
lineage contribute only slightly to overall marrow cellularity.
This study illustrates the potential role of quantitative MR
studies of the lumbar spine in patients with HD in determin-
ing marrow involvement and allowing the non-invasive
assessment of treatment responses. Quantitative MR studies
of larger areas of haemopoeitic bone marrow offer a method
of improving patient selection for ABMT. This is particularly
important as the technique carries a significant procedure
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related morbidity and mortality (Phillips & Reece, 1986).
Equally, quantitative MR studies of the lumbar marrow
could be applied to any solid tumour where bone marrow
involvement is an important factor that limits or dictates
therapeutic options.
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supported with a grant from The North West Cancer Research Fund.
References
BROXMEYER, H.E., LU LI., PLATZER, E., FEIT, C., JULIANO, L. &
RUBIN, B.Y. (1983). Comparative analysis of the influences of
human gamma, alpha and beta interferons on human multipoten-
tial (CFU-GEMM), erythroid (BFU-E) and granulocyte-
macrophage (CFU-GM) progenitor cells. Immunology, 131, 1300.
BRUNNING, R.D., BLOOMFIELD, C.D., McKENNA, R.W. & PETER-
SON, L. (1975). Bilateral trephine bone marrow biopsies in lym-
phoma and other neoplastic diseases. Ann. Intern. Med., 83, 365.
DOOMS, G.C., FISHER, M.R., HRICAK, H., RICHARDSON, M.,
CROOKS, L.E. & GENANT, H.K. (1985). Bone marrow imaging:
magnetic resonance studies related to age and sex. Radiology,
155, 429.
FULLERTON, G.D., POTTER, J.L. & DORNBLUTH, N.C. (1982). NMR
relaxation of proteins in tissues and other macromolecular solu-
tions. Mag. Reson. Imaging., 1, 209.
GORIN, N.C. (1986). Collection, manipulation and freezing of
haemopoeitic stem cells. Clin. Haematol., 15, 19.
JAGANNATH, S., DICKE, K.A., ARMITAGE, J.O. & 5 others (1986).
High-dose cyclophosphamide, carmustine and etoposide and
autologous bone marrow transplantation for relapsed Hodgkin's
disease. Ann. Intern. Med., 104, 163.
KAPADIA, S.B. & BAUSE, J.R. (1981). Hodgkin's Disease In Bone
Marrow Biopsy, Kraue, J.R. (ed) p. 146. Churchill Livingstone:
Edinburgh.
KESSINGER, A., ARMITAGE, J.O., LANDMARK, J.D., SMITH, D.M. &
WEISENBURGER, D.D. (1988). Autologous peripheral
haemopoietic stem cell transplantation restores haemopoeitic
function following marrow ablative therapy. Blood, 71, 723.
MOORE, S.G., GOODING, G.A., BRASCH, R.C. & 5 others (1986).
Bone marrow in children with acute lymphocytic leukaemia: MR
relaxation times. Radiology, 160, 237.
NYMAN, R., REHN, S., GLIMELIUS, B. & 5 others (1987). Magnetic
resonance imaging in diffuse malignant bone marrow diseases.
Acta Radiol., 28, 199.
OLSON, D.O., SHIELDS, A.F., SCHEURICH, C.J., PORTER, B.A. &
MOSS, A.A. (1986). Magnetic resonance imaging of the bone
marrow in patients with leukaemia, aplastic anaemia, and lym-
phoma. Invest. Radiol., 21, 540.
PHILLIPS, G.L. & REECE, D.E. (1986). Clinical studies of autologous
bone marrow transplantation in Hodgkin's disease. Clin.
Haematol., 15, 151.
RICHARDS, M.A., WEBB, J.A.W., JEWELL, S.E., AMESS, J.A.L.,
WRIGLEY, P.F.M. & LISTER, T.A. (1988a). Low field strength
magnetic resonance imaging of the bone marrow in patients with
malignant lymphoma. Br. J. Cancer, 57, 412.
RICHARDS, M.A., WEBB, J.A.W., JEWELL, S.E., GREGORY, W.M. &
REZNEK, R.H. (1988b). In vivo measurement of spin lattice relaxa-
tion time (TI) of bone marrow in healthy volunteers: the effects
of age and sex. Br. J. Radiol., 61, 30.
SHIELDS, A.F., PORTER, B.A., CHURCHLEY, S., OLSON, D.A.,
APPELBAUM, F.R. & DONNALL THOMAS, E. (1987). The detec-
tion of bone marrow involvement by lymphoma using magnetic
resonance imaging. J. Clin. Oncol., 5, 225.
SMITH, SR.,WILLIAMS, C.E., DAVIES, J.M. &EDWARDS, R.H.T. (1989).
Characterisation of bone marrow disorders by quantitative
magnetic resonance imaging. Radiology, 172, 805.
THOMAS, E.D. & STORB, R. (1970). Technique for human marrow
grafting. Blood, 36, 507.
THOMSEN, C., SORENSEN, P.G., KARLE, H., CHRISTOFFERSEN, P. &
HENRIKSEN, 0. (1988). Prolonged bone marrow TI-relaxation in
acute leukaemia. In vivo tissue characterisation by magnetic
resonance imaging. Mag. Reson. Imaging, 5, 251.
VOGLER, J.B. & MURPHY, W.A. (1988). Bone marrow imaging.
Radiology, 168, 679.